|
RPRD1A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62503344114384E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.65894031423886E-15 |
| Normal-vs-Stage2 |
5.805300E-04 |
| Normal-vs-Stage3 |
6.85251855259139E-12 |
| Normal-vs-Stage4 |
6.18509999883443E-08 |
| Stage1-vs-Stage2 |
1.071760E-01 |
| Stage1-vs-Stage3 |
9.036000E-01 |
| Stage1-vs-Stage4 |
5.426000E-01 |
| Stage2-vs-Stage3 |
8.962000E-02 |
| Stage2-vs-Stage4 |
7.390200E-02 |
| Stage3-vs-Stage4 |
6.078800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.88178419700125E-16 |
| Normal-vs-AfricanAmerican |
4.35560000000557E-05 |
| Normal-vs-Asian |
8.79729999958556E-07 |
| Caucasian-vs-AfricanAmerican |
6.503400E-01 |
| Caucasian-vs-Asian |
7.232600E-01 |
| AfricanAmerican-vs-Asian |
5.171400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16370033001567E-10 |
| Normal-vs-Female |
1.62525548574877E-12 |
| Male-vs-Female |
6.436200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.03090885722668E-14 |
| Normal-vs-Age(41-60Yrs) |
5.25246512950162E-13 |
| Normal-vs-Age(61-80Yrs) |
6.43709999748054E-08 |
| Normal-vs-Age(81-100Yrs) |
2.118000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.908770E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.895790E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.401200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.349800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.499200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.883200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.156600E-01 |
| Classical-VS-Follicular |
2.16669999997254E-06 |
| Classical-VS-Other |
4.405200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
2.159700E-03 |
| Tall-VS-Other |
3.475400E-01 |
| Tall-VS-Normal |
8.77860000247921E-08 |
| Follicular-VS-Other |
4.337800E-01 |
| Follicular-VS-Normal |
1.075110E-03 |
| Other-VS-Normal |
3.883700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.96289717392074E-11 |
| Normal-vs-N1 |
8.87000000115989E-08 |
| N0-vs-N1 |
2.303000E-01 |
|
|
